Buck Stops at the Top With FDA Enforcement
Being the CEO of a U.S. biopharma company is a whole lot riskier these days as the FDA continues to keep its promise to hold corporate officials accountable for the off-label promotion activities of their companies and employees.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter